You are here

BeiGene

Hong Kong could become biotech listing hub, says BeiGene boss as Chinese drug maker gears up for US$1 billion flotation

South China Morning Post

Mon, 07/30/18 - 11:12 am

BeiGene Proposes $800+ Million Offering

CP Wire

Fri, 07/27/18 - 11:50 am

BeiGene Proposes $800+ Million Offering

Fri, 07/27/18 - 10:37 am

BeiGene Initiates Ph III Trial of PD-1 Inhibitor Tislelizumab + Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer in China

CP Wire

Wed, 07/25/18 - 03:11 pm

monoclonal antibodies

BeiGene Initiates Ph III Trial of PD-1 Inhibitor Tislelizumab + Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer in China

Wed, 07/25/18 - 09:49 am

checkpoint inhibitors

Number 7? Celgene partner BeiGene joins the crowd with stellar PD-1/L1 data from a pivotal test

Endpoints

Mon, 07/23/18 - 09:45 am

Hodgkin's lymphoma

BeiGene Initiates Phase 3 Trial of Pamiparib as Maintenance Therapy in Patients with Ovarian Cancer

CP Wire

Thu, 05/17/18 - 12:03 pm

clinical trials

BeiGene Initiates Phase 3 Trial of Pamiparib as Maintenance Therapy in Patients with Ovarian Cancer

Thu, 05/17/18 - 09:53 am

2 Biotech Stocks Near All-Time Highs: Can They Keep Climbing?

Motley Fool

Mon, 03/19/18 - 11:41 am

Boehringer, BeiGene enter manufacturing pact for PD-1 drug

Biopharma Dive

Thu, 01/11/18 - 11:54 pm

Boehringer Ingelheim

drug manufacturing

Unstoppable growth of Chinese biotechs attracts over $10bn funding

GoinPharma

Mon, 11/27/17 - 09:07 am

Prescribed Reading: I/O is the only game in town

BioPharma Dive

Sat, 07/8/17 - 10:02 am

immuno-oncology

Endo International

Vertex Pharmaceuticals

Bristol-Myers Squibb

Celgene joins the PD-1 checkpoint club, bagging BeiGene drug with $413M down and $1B on the table

Endpoints

Thu, 07/6/17 - 09:33 am

China's BeiGene banks $97M to get its cancer drugs into the clinic

Fierce Biotech

Wed, 05/13/15 - 11:22 am

China Biotech In Review: Eli Lilly Joins The Big Pharmas Accused Of Bribing In China

Seeking Alpha

Sun, 08/25/13 - 11:33 am

Zhejiang Beta Pharma

China Biotech In Review: Valeant Pharma Gains Sales Foothold In China With Bausch & Lomb Buy

Seeking Alpha

Sun, 06/2/13 - 11:49 am

Valeant Pharmaceuticals

Tongjitang Chinese Medicines

Sinovac Biotech

Vigoo Biological

BeiGene And Merck & Co To Discover Cancer Medicines

Pharmceutical Insight

Sat, 05/28/11 - 02:03 pm

China’s Cancer Deaths Spur Merck Investment in Beijing Biotech

Bloomberg

Wed, 05/25/11 - 07:21 pm

Pages